ALNYLAM PHARMACEUTICALS, INC. Other Non-current Liabilities 2009-2025 | ALNY
Beta
What is ALNYLAM PHARMACEUTICALS, INC.'s current other non-current liabilities?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual other non-current liabilities for 2025 was $7.6M, a 52.83% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. other non-current liabilities for the quarter ending December 31, 2025 was $7.6M.
What was ALNYLAM PHARMACEUTICALS, INC.'s other non-current liabilities in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual other non-current liabilities for 2024 was $5.0M, a 98.39% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s other non-current liabilities in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual other non-current liabilities for 2023 was $308.4M, a 45.09% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year other non-current liabilities CAGR?
ALNYLAM PHARMACEUTICALS, INC. other non-current liabilities grew at a compound annual growth rate (CAGR) of 27.50% from FY2020 to FY2025, going from $37.9M to $7.6M over 5 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-27.5%
FY2020
$37.9M
→
FY2025
$7.6M
0910111516171819202122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $7.6M | +52.8% | 10-K |
| FY2024 | $5.0M | -98.4% | 10-K |
| FY2023 | $308.4M | +45.1% | 10-K |
| FY2022 | $212.6M | +114.8% | 10-K |
| FY2021 | $99.0M | +161.1% | 10-K |
| FY2020 | $37.9M | +306.3% | 10-K |
| FY2019 | $9.3M | +87.9% | 10-K |
| FY2018 | $5.0M | +14.2% | 10-K |
| FY2017 | $4.3M | +41.7% | 10-K |
| FY2016 | $3.1M | +135.7% | 10-K |
| FY2015 | $1.3M | +81.7% | 10-K |
| FY2011 | $716,000 | +400.7% | 10-K |
| FY2010 | $143,000 | -26.3% | 10-K |
| FY2009 | $194,000 | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →